Delvin Klarvoyant Biogenics Private Limited - Company Profile

It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2011.
2011 Chennai, Tamil Nadu, India Active
Last Updated:
Access Report
About Delvin Klarvoyant Biogenics Private Limited

Delvin Klarvoyant Biogenics Private Limited, a active private limited company, was established on 19 January 2011 in Chennai, Tamil Nadu, India. Engaging in api manufacturers within the trade sector, it holds CIN: U24100TN2011PTC078875. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹2.50 Cr and a paid-up capital of ₹1.21 Cr.

Formerly known as Klarvoyant Biogenics Private Limited. It upholds a active non-compliant status. Employing 1 professional, Its leadership includes Sebi Kattappilly Pius (Director), Rajesh Payyan Vellattunkara (Director), Deepu Mathew (Director). Past directors included Jaganathan Jayaseelan, Lenin Raveendran, Rajesh Payyan Vellattunkara. It holds ₹1.50 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2017, with the balance sheet filed on 31 March 2017. It is based at Plot No.15, Door No.2, 2Nd Floor Viswasa Nagar Main Road, Maduravoyal, Chennai, Tamil Nadu, 600095.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100TN2011PTC078875

  • Registration Number

    078875

  • Incorporation Date

    19 January 2011

  • Authorized Capital

    ₹2.50 Cr

  • Paid-Up Capital

    ₹1.21 Cr

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.50 Cr
  • Paid Up Capital ₹ 1.21 Cr
  • Company Age 15 Year, 2 Months
  • Last Filing with ROC 31 Mar 2017
  • Open Charges ₹ 1.50 Cr
  • Revenue Growth **** -30.44%
  • Profit Growth **** 52.23%
  • Ebitda **** 25.96%
  • Net Worth -80.18%
  • Total Assets -15.49%
Company report

Delvin Klarvoyant Biogenics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Delvin Klarvoyant Biogenics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Delvin Klarvoyant Biogenics Private Limited?
Current Directors
Name Designation Appointment Date Status
Sebi Kattappilly Pius Director 19 Jan 2011 Current
Rajesh Payyan Vellattunkara Director 12 Nov 2017 Current
Deepu Mathew Director 12 Nov 2017 Current
Rahul Pulickal Raj Director 12 Nov 2017 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 12 Nov 2017 Past
Pramod Abcsdd Director 12 Jan 2015 Past
Pramod Abcsdd Director 16 Mar 2015 Past
Pramod Abcsdd Director 16 Mar 2015 Past
Pramod Abcsdd Additional Director 12 Jan 2015 Past
Pramod Abcsdd Director 12 Jan 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Delvin Klarvoyant Biogenics.

Delvin Klarvoyant Biogenics Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 30.44% decrease. The company also saw a substantial improvement in profitability, with a 52.23% increase in profit. The company's net worth observed a substantial decline by a decrease of 80.18%.

Delvin Klarvoyant Biogenics revenue growth over time
Delvin Klarvoyant Biogenics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -30.44%
*******
*******
*******
*******
Revenue from Operations
*******
 -30.57%
*******
*******
*******
*******
Total Assets
*******
 -15.49%
*******
*******
*******
*******
Profit or Loss
*******
 52.23%
*******
*******
*******
*******
Net Worth
*******
 -80.18%
*******
*******
*******
*******
EBITDA
*******
 25.96%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Delvin Klarvoyant Biogenics?

In 2017, Delvin Klarvoyant Biogenics had a promoter holding of 83.47% and a public holding of 16.53%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹15,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 1.50 Cr
Latest Charge Details
Date Lender Amount Status
11 Jul 2016 Others ₹1.50 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Delvin Klarvoyant Biogenics?

Delvin Klarvoyant Biogenics has a workforce of 1 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Delvin Klarvoyant Biogenics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Delvin Klarvoyant Biogenics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Delvin Klarvoyant Biogenics
Recent Activity within the Organization
  • Director Appointment

    The activity Rajesh Payyan Vellattunkara was appointed as a Director was appointed as a Director on 12 Nov 2017 & has been associated with this company since 8 years 4 months . was completed.

  • Director Appointment

    Progress on Deepu Mathew was appointed as a Director was appointed as a Director on 12 Nov 2017 & has been associated with this company since 8 years 4 months . was documented.

  • Director Appointment

    The activity Rahul Pulickal Raj was appointed as a Director was appointed as a Director on 12 Nov 2017 & has been associated with this company since 8 years 4 months . was completed.

  • Annual General Meeting

    The activity Delvin Klarvoyant Biogenics Private Limited last Annual general meeting of members was held on 30 Sep 2017 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Delvin Klarvoyant Biogenics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Chennai. was documented.

  • Charges

    The activity A charge with Others amounted to Rs. 1.50 Cr with Charge ID 100054118 was registered on 11 Jul 2016. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Delvin Klarvoyant Biogenics Private Limited?

The CIN of Delvin Klarvoyant Biogenics Private Limited is U24100TN2011PTC078875.

Where is Delvin Klarvoyant Biogenics Private Limited headquartered?

Delvin Klarvoyant Biogenics Private Limited is headquartered at Plot No.15, Door No.2, 2Nd Floor Viswasa Nagar Main Road, Maduravoyal, Chennai, Tamil Nadu, 600095.

When was Delvin Klarvoyant Biogenics Private Limited incorporated?

Delvin Klarvoyant Biogenics Private Limited was incorporated on 19 January 2011.

Who are the current directors of Delvin Klarvoyant Biogenics Private Limited?

The current directors of Delvin Klarvoyant Biogenics Private Limited are

What is the primary industry of Delvin Klarvoyant Biogenics Private Limited?

The primary industry of Delvin Klarvoyant Biogenics Private Limited is Trade.

Is Delvin Klarvoyant Biogenics Private Limited a listed company?

Delvin Klarvoyant Biogenics Private Limited is unlisted.

What is the capital structure of Delvin Klarvoyant Biogenics Private Limited?

The authorized capital of Delvin Klarvoyant Biogenics Private Limited is ₹2.50 Cr, and the paid-up capital is ₹1.21 Cr.

What is the compliance status of Delvin Klarvoyant Biogenics Private Limited?

The compliance status of Delvin Klarvoyant Biogenics Private Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available